18,688.48 27,642.26 (8,953.78) (32.39) Administrative expenses 913.70 745.76 167.94 22.52 Total expenses 19,602.18 28,388.02 (8,785.84) (30.95) Profit before share of profit (loss) from investments in

Baht or 35.36% from the same period last year due to the Company has default of interest increased from the same period last year. 5. Loss for the period was 882.35 million Baht, increased amount of

– Unrealized gain / (loss) from FX – Non-recurring income / (expense) KEY FINANCIAL HIGHLIGHT Sales and Service Income  Sales and service income increased 14.6% year- on-year from Baht 20,691 million for 9M

also had a forex loss of Baht 5 . 1 3 million, which was a loss on foreign exchange. The need to improve foreign debtors' accounts at the end of the year was due to the continued appreciation of the baht

sell promotion expenses and maintenances expenses. Loss from fair value adjustment on investment property The Company incurred gain from fair value adjustment on investment property in 2017 which results

. Loss from fair value adjustment on investment property The Company incurred gain from fair value adjustment on investment property in 2017 which results loss 6.4 million baht. The investment property

expenses was 1,719 MTHB, increased by 546 MTHB or 47% from 2016. This increment was mainly from the loss on written-off and disposal of plant and equipments and intangible assets of Solvay Biochemicals

bill amount per patient. Operation : Consolidated Profit & Loss Statement 4Q 4Q % 12 mth 12 mth % Unit : THB million 2017 2016 change 2017 2016 change Revenue from non-social security 197.87 182.46 8

หลักทรัพย์ (Gain (loss) on Securities trading) หมายถึง กำไรหรือขาดทุนจากการซื้อขายหลักทรัพย์ ในกรณีที่มีค่าใช้จ่ายจากการขายหลักทรัพย์หรือมีผลกำไรขาดทุนจากการตีราคาหลักทรัพย์ ให้นำมาปรับปรุงรายการนี้เพื่อ

any responsibility for its accuracy, nor be held liable for any loss or damages arising from or related to its use. ------------------------------- Notification of the Office of the Securities and